Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC (CIK: 0001989138) EDGAR, Information, Filings... CompaniesBIO.Com

Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC

Mailing address
2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703
Phone
(360) 946-0604
State location
Delaware
State of incorporation
Delaware
Fiscal year end
December 31
SIC
N/A
Filings
N/A

Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC (CIK: 0001989138) is an American company incorporated in the state of Delaware. Head office is located at 2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703. Work in the industry N/A. Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0001989138-23-000001 (33 Act) Size: KB	Aug-09-2023	021-489211 231154295

Recent 20 filings. View all Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC overview
Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC job
Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC stock
Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC ownership
Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC CEO
Visus Therapeutics Mar 2023 a Series of Qima Ventures LLC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.